早期食管腺癌患者食管切除术与内镜下切除术比较:美国国家癌症数据库倾向性匹配研究
该研究基于美国国家癌症数据库,比较T1a期食管腺癌患者接受食管切除术或内镜下切除术的结局。经倾向性匹配形成735对均衡队列。匹配队列中食管切除术组住院时间更长、30天内再入院率更高(7.0% vs 0.6%,P < .001);内镜下切除术在术后0至90天死亡风险更低(HR 0.15,P = .003),但90天后生存期食管切除术可能更优(HR 1.34,P = .02)。
要点
- 匹配队列中食管切除术组30天再入院率7.0%,内镜下切除术组0.6%(P < .001)。
- 术后0至90天,内镜下切除术死亡风险低于食管切除术(HR 0.15,P = .003)。
- 生存超过90天者,食管切除术可能提供更好的总生存(HR 1.34,P = .02)。
核心结论
- 早期食管腺癌患者接受内镜下切除术或食管切除术的生存似乎相当,但内镜下切除术与更短住院时间、更少再入院和更低90天死亡率相关。
- 生存超过90天的患者,食管切除术可能提供更好的总生存。
研究设计与样本
- 基于美国国家癌症数据库的倾向性匹配研究,纳入接受食管切除术或内镜下切除术的T1a期食管腺癌患者。
- 共识别2173例患者,其中1317例(60.6%)接受食管切除术,856例(39.4%)接受内镜下切除术。
- 使用倾向性评分匹配生成735对均衡队列,并对匹配及未匹配队列进行多变量Cox回归分析。
主要发现
- 未匹配队列中,食管切除术组患者更年轻、更多不在学术机构治疗、更可能有合并症(30.4% vs 22.5%,P = .002),且住院时间更长、再入院更多。
- 影响总生存的积极因素包括更年轻、在学术医学中心切除以及更低的Charlson-Deyo合并症评分。
- 匹配队列中,食管切除术组住院时间更长,30天内再入院率更高(7.0% vs 0.6%,P < .001)。
- 按时间分段分析,内镜下切除术在术后0至90天死亡风险更低(HR 0.15,P = .003),但90天后生存期风险逆转(HR 1.34,P = .02)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVES: Endoscopic resection has been rapidly adopted in the treatment of early-stage esophageal tumors. We compared the outcomes after esophagectomy or endoscopic resection for stage T1a adenocarcinoma. METHODS: We queried the National Cancer Database for patients with T1a esophageal adenocarcinoma who underwent esophagectomy or endoscopic resection and generated a balanced cohort with 735 matched pairs using propensity-score matching. We then performed a multivariable Cox regression analysis on the matched and unmatched cohorts. RESULTS: We identified 2173 patients; 1317 (60.6%) underwent esophagectomy, and 856 (39.4%) underwent endoscopic resection. In the unmatched cohort, patients who underwent esophagectomy were younger, more often not treated in academic settings, and more likely to have comorbidities (30.4% vs 22.5%, P = .002). They had longer hospital stays and more readmissions than patients who underwent endoscopic resection. Factors positively affecting overall survival were younger age, resection at an academic medical center, and lower Charlson-Deyo comorbidity score. In the matched cohort, patients who underwent esophagectomy had longer hospital stays and were more likely to be readmitted within 30 days (7.0% vs 0.6%, P < .001). When a time period-specific partition was applied, endoscopic resection had a lower death hazard 0 to 90 days after resection (hazard ratio, 0.15; P = .003), but this was reversed for survival greater than 90 days (hazard ratio, 1.34; P = .02). CONCLUSIONS: In patients with early-stage esophageal adenocarcinoma, survival appears equivalent after endoscopic resection or esophagectomy, but endoscopic resection is associated with shorter hospital stays, fewer readmissions, and less 90-day mortality. In patients surviving more than 90 days, esophagectomy may provide better overall survival.
引用
- Marino KA, Sullivan JL, Weksler B, et al. Esophagectomy versus endoscopic resection for patients with early-stage esophageal adenocarcinoma: A National Cancer Database propensity-matched study. J Thorac Cardiovasc Surg. 2018. PMID: 29455958. doi:10.1016/j.jtcvs.2017.11.111
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。